Literature DB >> 28353200

Asymptomatic acute hepatitis E in a female patient with ulcerative colitis.

Kazuyuki Suzuki1,2,3, Ichiro Kumagai4, Yuichi Yoshida5, Akio Miyasaka5, Yasuhiro Takikawa5, Ryoichi Kamiya4, Kouryo Kondo4, Akinobu Kato4, Toshimi Chiba6, Hiroaki Okamoto7.   

Abstract

We present a 60-year-old female patient with asymptomatic acute hepatitis E that was fortuitously detected during the course of ulcerative colitis (UC). She was admitted to hospital on October 30, 2015. Endoscopy and histological examination of the colon showed typical findings of UC. All parameters of liver function tests were normal on this date. Combination therapy with oral prednisolone and mesalazine was started and intravenous administration of infliximab once every 8 weeks was added later. Her symptoms gradually improved after these treatments, and she was discharged on February 7, 2016. In a periodic check-up on July 7, 2016, high levels of serum transaminases were detected in liver function tests. Although drug-induced liver injury was first suspected, anti-hepatitis E virus (HEV) immunoglobulin A was positive. The genotype and subgenotype of this HEV are 3 and 3a, respectively, although the infectious route of the HEV was unclear. Within 2 weeks after the onset of acute liver injury, the HEV viremia disappeared and her liver function tests improved. Examination of serum anti-HEV immunoglobulin A should be added at the time of abnormal liver function tests in patients with UC receiving immunosuppressive and biological drugs.

Entities:  

Keywords:  Acute hepatitis E; Biological drug; Immunosuppressive drug; Opportunistic infection; Ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 28353200     DOI: 10.1007/s12328-017-0730-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  36 in total

1.  Consumption of wild boar linked to cases of hepatitis E.

Authors:  Yoko Tamada; Koji Yano; Hiroshi Yatsuhashi; Osami Inoue; Fumihiro Mawatari; Hiromi Ishibashi
Journal:  J Hepatol       Date:  2004-05       Impact factor: 25.083

Review 2.  Pathogenesis and treatment of hepatitis e virus infection.

Authors:  Heiner Wedemeyer; Sven Pischke; Michael P Manns
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

3.  Dynamic epidemiology of acute viral hepatitis in Japan.

Authors:  Koji Yano; Yoko Tamada; Hiroshi Yatsuhashi; Atsumasa Komori; Seigo Abiru; Kiyoaki Ito; Naohiko Masaki; Masashi Mizokami; Hiromi Ishibashi
Journal:  Intervirology       Date:  2010-01-05       Impact factor: 1.763

Review 4.  Zoonotic transmission of hepatitis E virus in industrialized countries.

Authors:  Franco Maria Ruggeri; Ilaria Di Bartolo; Eleonora Ponterio; Giorgia Angeloni; Marcello Trevisani; Fabio Ostanello
Journal:  New Microbiol       Date:  2013-10-01       Impact factor: 2.479

5.  Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).

Authors:  C Loras; J P Gisbert; M C Saro; M Piqueras; C Sánchez-Montes; J Barrio; I Ordás; A Montserrat; R Ferreiro; Y Zabana; M Chaparro; F Fernández-Bañares; M Esteve
Journal:  J Crohns Colitis       Date:  2014-07-19       Impact factor: 9.071

6.  Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.

Authors:  Patrícia Andrade; João Santos-Antunes; Susana Rodrigues; Susana Lopes; Guilherme Macedo
Journal:  J Gastroenterol Hepatol       Date:  2015-11       Impact factor: 4.029

7.  Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan.

Authors:  Hitoshi Mizuo; Kazuyuki Suzuki; Yasuhiro Takikawa; Yoshiki Sugai; Hajime Tokita; Yoshihiro Akahane; Keiichi Itoh; Yuhko Gotanda; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A.

Authors:  Shigehiko Sainokami; Koichi Abe; Ichiro Kumagai; Akio Miyasaka; Ryujin Endo; Yasuhiro Takikawa; Kazuyuki Suzuki; Hitoshi Mizuo; Yoshiki Sugai; Yoshihiro Akahane; Yoichi Koizumi; Yoshiaki Yajima; Hiroaki Okamoto
Journal:  J Gastroenterol       Date:  2004-07       Impact factor: 7.527

9.  Epidemiology of hepatitis E in Northeastern China, South Korea and Japan.

Authors:  Miyuki Taniguchi; Soo Ryang Kim; Shunji Mishiro; Kazuaki Takahashi; Myung Hee Shin; Haesun Yun; Man Suk Park; Zhong Min Li; Mi Kyung Kim; Jinnv Fang; Yoshitake Hayashi
Journal:  J Infect       Date:  2009-02-26       Impact factor: 6.072

10.  A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan.

Authors:  Yuki Inagaki; Yukio Oshiro; Tomohiro Tanaka; Tomoharu Yoshizumi; Hideaki Okajima; Kohei Ishiyama; Chikashi Nakanishi; Masaaki Hidaka; Hiroshi Wada; Taizo Hibi; Kosei Takagi; Masaki Honda; Kaori Kuramitsu; Hideaki Tanaka; Taiji Tohyama; Toshihiko Ikegami; Satoru Imura; Tsuyoshi Shimamura; Yoshimi Nakayama; Taizen Urahashi; Kazumasa Yamagishi; Hiroshi Ohnishi; Shigeo Nagashima; Masaharu Takahashi; Ken Shirabe; Norihiro Kokudo; Hiroaki Okamoto; Nobuhiro Ohkohchi
Journal:  EBioMedicine       Date:  2015-11       Impact factor: 8.143

View more
  3 in total

Review 1.  Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?

Authors:  Salvatore Di Bartolomeo; Francesco Carubbi; Paola Cipriani
Journal:  BMC Rheumatol       Date:  2020-09-21

2.  Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study.

Authors:  Sven Pischke; Jean-Marie Peron; Moritz von Wulffen; Johann von Felden; Christoph Höner Zu Siederdissen; Sophie Fournier; Marc Lütgehetmann; Christoph Iking-Konert; Dominik Bettinger; Gabriella Par; Robert Thimme; Alain Cantagrel; Ansgar W Lohse; Heiner Wedemeyer; Robert de Man; Vincent Mallet
Journal:  Viruses       Date:  2019-02-22       Impact factor: 5.048

3.  Molecular Characterization and Seroprevalence of Hepatitis E Virus in Inflammatory Bowel Disease Patients and Solid Organ Transplant Recipients.

Authors:  Juozas Grigas; Maria Montoya; Evelina Simkute; Marius Buitkus; Ruta Zagrabskaite; Arnoldas Pautienius; Dainius Razukevicius; Laimas Virginijus Jonaitis; Gediminas Kiudelis; Jurgita Skieceviciene; Ruta Vaiciuniene; Asta Stankuviene; Inga Arune Bumblyte; Juozas Kupcinskas; Arunas Stankevicius
Journal:  Viruses       Date:  2021-04-13       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.